These results suggested that neutralizing antibody specific for BDNF or Trk tyrosine kinase inhibitor K252a against TrkB probably antagonized the protection of BDNF/TrkB for HCC cells. The gene discussed is NTRK2; the disease is hepatocellular carcinoma.